You are here

Article Text

Article menu
Download PDFPDF
Correspondence
Antinuclear antibodies in relapsing polychondritis
  1. JEAN-CHARLES PIETTE,
  2. ROULA EL-RASSI,
  3. ZAHIR AMOURA
  1. Internal Medicine Unit, Hôpital Pitié-Salpêtrière, 83 Boulevard de l’Hôpital, 75651 Paris Cedex 13 France
  1. Dr J-C Piette.

https://doi.org/10.1136/ard.58.10.656

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The prevalence of antinuclear antibodies (ANA) in relapsing polychondritis (RP) has been recently reported by Zeuneret al to be as high as 66%,1usually in a low titre with a speckled pattern. We report here on our experience of ANA testing in patients with RP.

    The charts of 180 patients followed up in our institution fulfilling the criteria for RP proposed by Michet et al 2 have been recently retrospectively reviewed, with special focus on dermatological manifestations and their relation with myelodysplasia.3 ,4 This aim led us to exclude 36 patients because the association of RP with potentially confounding diseases,3 such as systemic lupus erythematosus (SLE) present in nine, mixed connective tissue disease (MCTD) in …

    View Full Text